MAM
MED icon

Meeder Asset Management’s Medifast MED Stock Holding History

Meeder Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,866
Closed -$225K – 940
2024
Q1 		$225K Sell
5,866
-5,318
-48% -$258K 0.01% 293
2023
Q4 		$752K Buy
+11,184
New +$779K 0.06% 154
2023
Q3 		– Sell
-14,622
Closed -$1.35M – 557
2023
Q2 		$1.35M Buy
14,622
+10,489
+254% +$934K 0.1% 140
2023
Q1 		$428K Buy
+4,133
New +$458K 0.03% 208
2022
Q3 		– Sell
-1
Closed – – 2273
2022
Q2 		$0 Sell
1
-4
-80% -$716 ﹤0.01% 2328
2022
Q1 		$1K Buy
+5
New +$943 ﹤0.01% 2208
2021
Q4 		– Sell
-21
Closed -$4K – 1846
2021
Q3 		$4K Hold
21
– – ﹤0.01% 2010
2021
Q2 		$6K Hold
21
– – ﹤0.01% 1879
2021
Q1 		$5K Buy
21
+17
+425% +$4.07K ﹤0.01% 1862
2020
Q4 		$1K Buy
+4
New +$707 ﹤0.01% 1689
2020
Q2 		– Sell
-77
Closed -$5K – 2295
2020
Q1 		$5K Sell
77
-40
-34% -$3.64K ﹤0.01% 1789
2019
Q4 		$12K Buy
117
+22
+23% +$2.13K ﹤0.01% 1510
2019
Q3 		$10K Hold
95
– – ﹤0.01% 1543
2019
Q2 		$12K Buy
95
+75
+375% +$10.4K ﹤0.01% 1406
2019
Q1 		$3K Hold
20
– – ﹤0.01% 1499
2018
Q4 		$3K Sell
20
-187
-90% -$32K ﹤0.01% 1513
2018
Q3 		$45K Sell
207
-232
-53% -$47K ﹤0.01% 809
2018
Q2 		$70.3K Sell
439
-866
-66% -$111K 0.01% 690
2018
Q1 		$123K Sell
1,305
-461
-26% -$34.4K 0.01% 519
2017
Q4 		$123K Sell
1,766
-157
-8% -$10.4K 0.01% 538
2017
Q3 		$114K Sell
1,923
-2,979
-61% -$148K 0.01% 544
2017
Q2 		$203K Buy
+4,902
New +$213K 0.02% 470

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Meeder Asset Management's MED Position: Q2 2024 in Review

Meeder Asset Management sold out of Medifast (MED) in Q2 2024, closing a stake of 5,866 shares — an estimated $225K sold.

Meeder Asset Management first reported a position in MED in Q2 2017 and held it in 22 quarters. The position peaked at $1.35M in Q2 2023. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Meeder Asset Management reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Meeder Asset Management sold 5,866 Medifast shares in Q2 2024, an estimated $225K.
  • Meeder Asset Management first reported a position in Medifast in Q2 2017 and held it in 22 quarters.
  • Meeder Asset Management's Medifast position peaked at $1.35M in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Meeder Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.